Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2012/0093763 |
RNA VIRUS INFECTION INHIBITOR, METHOD FOR INHIBITION OF INFECTION BY RNA
VIRUS, RNA VIRUS INFECTION-INHIBITING... Disclosed herein is an RNA virus infection inhibitor that is capable of effectively inhibiting humans from being infected with RNA viruses to prevent the... |
| 2012/0093762 |
NUCLEIC ACID DELIVERY COMPOUNDS Polymers including two or more different recurring units are disclosed herein. Also disclosed herein are methods of using such polymers to deliver nucleic acids... |
| 2012/0093761 |
VACCINE COMPOSITIONS AND METHODS OF USE THEREOF Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody... |
| 2012/0093760 |
POLYQUATERNIUM-1 SYNTHESIS METHODS The present embodiments relate to a novel method of making quaternary ammonium polymers comprising the steps of: a) mixing 1,4-bis-dimethylamino-2-butene,... |
| 2012/0093759 |
Medical Devices, Wound Dressings, and Methods for Dressing Wounds Medical devices, wound dressings, and methods of dressing wounds are described. Devices and methods using silicone and pharmaceutically active agents are... |
| 2012/0093758 |
Hair Cosmetic The present invention provides a hair cosmetic composition contains (A) a di-long-chain cationic surfactant represented by formula (1); (B) an ethylene oxide... |
| 2012/0093757 |
COMPOSITION Hair conditioner comprising silicone and a conditioning gel phase, said phase obtainable by heating a fatty alcohol and an oil until they are molten, separately... |
| 2012/0093756 |
CONCENTRATED SHAMPOO Concentrated shampoo composition comprising from 27 to 70% wt. cleansing surfactant, a conditioning gel phase, a short chain diol and an oil, wherein the... |
| 2012/0093755 |
COMPOSITIONS AND METHODS FOR TREATING KERATIN BASED FIBERS Compositions, formulations, kits and methods for temporarily or semi-permanently transforming the shape of individual hair filaments or keratinous fibers... |
| 2012/0093754 |
Conditioning Composition for Keratin Fibres The present invention relates to a conditioning composition for keratin fibres especially human hair comprising particular cationic cellulose polymer and a... |
| 2012/0093753 |
CATIONIC POLYGLYCERYL COMPOSITIONS AND COMPOUNDS Provided are polyglyceryl compositions comprising one or more polyglyceryl compounds having: (a) a node structure comprising at least three contiguous glyceryl... |
| 2012/0093752 |
Use of Monoamine Oxidase Inhibitors to Improve Epithelial Biology The invention provides a method for improving hair biology, e.g., hair growth. The method comprises administering to a subject a monoamine oxidase inhibitor and... |
| 2012/0093751 |
Hair Cosmetic To provide means for improving tactile sensation of hair during application of a hair cosmetic composition, particularly a hair conditioner or a hair rinse,... |
| 2012/0093750 |
COSMETIC COMPOSITION MADE FROM ION-EXCHANGE RESINS FILLED WITH
LIPOAMINOACIDS Disclosed is a composition of ion-exchange resins made from a styrene-divinylbenzene copolymer or an acrylic-divinylbenzene copolymer filled with at least one... |
| 2012/0093749 |
USE OF DELTA-TOCOPHERYL-CARBOHYDRATE AS A DEPIGMENTING AGENT The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin. |
| 2012/0093748 |
TOPICAL PERSONAL CARE AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Topical compositions are provided that have 0.5% or more of at least one personal care or pharmaceutical acid, and lightly- to moderately-crosslinked PVP, which... |
| 2012/0093747 |
SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER A sunscreen cosmetic composition contains an ultraviolet absorber composed of a triazine compound (a) represented by the general formula (1) below and a... |
| 2012/0093746 |
AMINO ACID-MODIFIED ORGANOPOLYSILOXANE, MAKING METHOD, AND COSMETICS An amino acid-modified organopolysiloxane can be prepared under mild reaction conditions by reacting an amino-modified organopolysiloxane with an amino acid or... |
| 2012/0093745 |
PEPTIDIC HYDROLYZATE PROTEASOME ACTIVATORS AND COMPOSITIONS CONTAINING
SAME The present invention concerns a peptidic hydrolyzate enriched in bioactive peptides, said hydrolyzate being a proteasome activator. Further, the present... |
| 2012/0093744 |
MODIFIED OILS AND MULTIPLE EMULSIONS According to one aspect, the present invention relates to the use of a perfluoropolyether phosphate (PFPE phosphate), dissolved in water, for the preparation of... |
| 2012/0093743 |
ADDITION OF FLUORIDE TO BEVERAGES A system and method for preventing tooth decay comprises steps or acts of adding a small dose of fluoride to a carbonated or sugar-containing beverage to... |
| 2012/0093742 |
Compounds A method of modulating the flavour of an orally-receivable product, such as a foodstuff, beverage, dentifrice or medicine, comprising the addition thereto of a... |
| 2012/0093741 |
DENTAL MASKING COMPOUND A photopolymerizable dental composition for application to and for the isolation and protection of gums and/or teeth during dental treatment is described. The... |
| 2012/0093740 |
PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x... |
| 2012/0093739 |
METHOD FOR TREATING HAIR GROWTH DISORDERS, SUCH AS FEMALE PATTERN
ALOPECIA, AND COMPOSITIONS USEFUL THEREFORE The invention relates to formulations useful in treating hair disorders, improving the health of hair, increasing hair growth, and in increasing the niacin... |
| 2012/0093738 |
TASTE-MASKED ORAL FORMULATIONS OF INFLUENZA ANTIVIRALS The present invention relates to taste-masked oral formulations of influenza antivirals. The taste-masked pharmaceutical formulations for oral administration... |
| 2012/0093737 |
LIGHT-ABSORBING COMPOSITIONS AND METHODS OF USE The present disclosure relates to methods and compositions comprising naturally occurring light absorbing molecules for preventing damages from light exposure.... |
| 2012/0093736 |
REVERSIBLE COLOR-CHANGING INK FORMULATIONS AND NONWOVEN WIPES A reversible color-changing ink formulation, and a nonwoven wipe to which the ink formulation is securely bound, are provided. The reversible color-changing ink... |
| 2012/0093735 |
COMPLEX COMPOUND AND MRI PROBE MADE OF SAME Novel gadolinium complex compounds responsive to ions and compounds other than zinc ion, as well as MRI probes made of the compounds are disclosed. Since the... |
| 2012/0093734 |
PROTEIN-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF COLORECTAL
ADENOCARCINOMA Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma are disclosed. A method for identifying cell-surface proteins, which are... |
| 2012/0093733 |
MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND
METHODS OF THEIR USE In one embodiment, a biotag for targeting a cancer biomarker is provided. The biotag may include a cancer biomarker binding domain, an internalization domain,... |
| 2012/0093732 |
ULTRASOUND CONTRAST AGENTS AND METHODS OF MAKING AND USING THEM The invention is directed to injectable suspensions of gas-filled microvesicles, as well as methods of preparing and using the same, especially as ultrasound... |
| 2012/0093731 |
GAS-FILLED MICROVESICLES WITH TARGETING LIGAND OR THERAPEUTIC AGENT Gas-filled microvesicles comprising a boundary envelope containing a gas, wherein said microvesicles comprise: --a first component, bound to said envelope,... |
| 2012/0093730 |
MOLECULAR DEATH TAGS AND METHODS OF THEIR USE In one embodiment, a death tag for targeting a cell death marker is provided, the death tag comprising a death marker binding domain; a reporter binding domain... |
| 2012/0093729 |
NOVEL PHOSPHORUS-CONTAINING PRODRUGS Novel cyclic phosphoramidate prodrugs of drugs of formula I ##STR00001## their use in delivery of drugs to the liver, their use in enhancing oral bioavailability,... |
| 2012/0093728 |
MITOCHONDRIAL INHIBITORS TO TREAT HUMAN DISEASE The present invention relates to inhibitors of mitochondria-associated, granulocyte-macrophage colony stimulating factor signaling molecule (Magmas), and... |
| 2012/0093727 |
COMPOSITIONS AND METHODS FOR IN VIVO IMAGING OF MYELIN IN THE PERIPHERAL
NERVOUS SYSTEM A method of detecting and/or labeling myelin in an animal's peripheral nervous system tissue includes administering to the animal a fluorescent stilbenzene... |
| 2012/0093726 |
Radiolabeled Fluorine Derivatives of Methionine The invention provides compound which is an .sup.18F-radiolabelled S-propylhomocysteine or a derivative thereof. The compound has an enantiomeric purity of at... |
| 2012/0093725 |
Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies The present invention relates to the diagnosis of clinical conditions characterized by undesirable and/or abnormal selectin expression. In particular, the... |
| 2012/0093724 |
METHODS AND COMPOSITIONS FOR THE DETECTION OF CANCER Various embodiments of this invention relate generally to targeted activation and delivery of therapeutic drugs to cells that produce prostate specific antigen... |
| 2012/0093723 |
NANOCARRIER COMPOSITIONS AND METHODS This invention provides multimeric nanocarrier for in vivo delivery of a bioactive agent, comprising at least two peptide monomers reversibly or irreversibly... |
| 2012/0093722 |
SYNTHETIC DIBLOCK COPOLYPEPTIDE HYDROGELS FOR USE IN THE CENTRAL NERVOUS
SYSTEM This invention relates, e.g., to a composition suitable for administration to the central nervous system (CNS), comprising a block copolypeptide hydrogel, which... |
| 2012/0093721 |
USES OF CANCER-TARGETING PEPTIDES IN CANCER DIAGNOSIS Cancer-targeting peptides and uses thereof in cancer diagnosis. |
| 2012/0093720 |
Molecularly Imprinted Polymers for Use as Imaging and Therapeutics Agents The invention described herein provides biocompatible molecularly imprinted polymers (MIPs) that are non-toxic, water soluble, small molecular weight, and... |
| 2012/0093719 |
ANTIBODIES AGAINST PROSTATE SPECIFIC MEMBRANE ANTIGEN Antibodies (Ab) and antigen binding fragments capable of binding to prostate specific membrane antigen and which may be used for diagnostic and therapeutic... |
| 2012/0093718 |
LIPOSOMAL NANOPARTICLES AND OTHER FORMULATIONS OF FENRETINIDE FOR USE IN
THERAPY AND DRUG DELIVERY Formulations of neutral retinoids, in particular fenretinide (HPR) in the form of lipid nanoparticles, solid dipersions and emulsions are disclosed. These... |
| 2012/0093717 |
MICROSPHERE/NANOFIBER COMPOSITES FOR DELIVERY OF DRUGS, GROWTH FACTORS,
AND OTHER AGENTS Provided are compositions that include polymeric fibers and microspheres entrapped within the fibers, the compositions being capable of controlled delivery of... |
| 2012/0093716 |
USE OF ANTISECRETORY FACTORS (AF) FOR OPTIMIZING CELLULAR UPTAKE The present invention relates to the use of an antisecretory factor (AF) protein, peptide, derivative, homologue, and/or fragment thereof, having equivalent... |
| 2012/0093715 |
MONOLITHIC ZEOLITE STRUCTURES WITH AND WITHOUT HIERARCHICAL PORE
STRUCTURES AND METHODS FOR PRODUCING THE SAME Monolithic zeolite structures with hierarchical pore structures and methods for producing monolithic zeolite structures without the use of a solid template are... |
| 2012/0093714 |
High-Capacity Complex Hydrogen Storage Materials and a Process of
Releasing Hydrogen Disclosed herein provide compositions and hydrogen release methods for a high-capacity complex hydrogen storage material. The hydrogen storage material is... |
Copyright 2008−2013 Patents.com
